The tumour growth curve (Fig. 3B) over 21 days indicates that silencing ANXA2 reduced the tumourigenic potential (P<0.05) in vivo. The mice appeared emaciated and tumour weight was 1.89±0.16 g in the shRNA group (Fig. 3C). This evidence concerns the gene ANXA2 and neoplasm.